Benjamin Huffman is a synthetic organic chemist who earned his PhD at the Scripps Research Institute under the direction of Ryan Shenvi. Dr. Huffman has nine years of academic and industry experience and has co-invented or coauthored a combined 16 patents and peer-reviewed publications. At NICO Therapeutics, Dr. Huffman functions as a chemistry leader responsible for designing the structural features and synthetic blueprints of new small molecule drug candidates. As a grant reviewer, assessor and grant recipient of The Michael J. Fox Foundation, Dr. Huffman is committed to working with MJFF to achieve his long-term goal of accelerating novel therapeutics for the treatment of Parkinson’s disease to the clinic.
Associated Grants
-
Developing Novel Lysosome-based Translational Biomarkers and Ion-Channel Agonists as Therapeutics for Parkinson’s Disease
2025